Metformin: A potential adjunct for treatment of systemic mastocytosis

This publication has 43 references indexed in Scilit:

• Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
  PLOS ONE, 2013
• Metformin: an old but still the best treatment for type 2 diabetes
  Diabetology & Metabolic Syndrome, 2013
• Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells
  Cell Cycle, 2012
• The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
  Molecular Cancer Therapeutics, 2012
• Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
  Cancer Research, 2011
• Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
  Breast Cancer Research and Treatment, 2010
• Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy
  Current Medical Research and Opinion, 2010
• Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
  Cancer Research, 2009
• Metformin and reduced risk of cancer in diabetic patients
  BMJ, 2005
• Prospective identification of tumorigenic breast cancer cells
  Proceedings of the National Academy of Sciences, 2003